PhD in Biomedical Sciences (Pharmacology)

Drug development and Cell Signaling Research Group led by Dr. Muhammad Imran Khan is focused on the functions of various receptors and second messengers involved in the mechanism of drug action. Our projects include interaction of drug molecules with various genes, proteins and to explore the fundamental molecular mechanisms of neuropsychiatric and neurodegenerative disorders. Our team is also actively working on other diseases considering: receptor plasticity, activation mechanism, signaling bias, ligand binding, the effect of the membrane and other interaction partners involved as a result of drug treatment or underlying disease. In 2021, pharmaceutical industry boosted with a final revenue of 1.42 trillion US dollars worldwide. The future perspective of this group is to develop indigenous ELISA based disease diagnostic kits and novel therapeutic interventions for better clinical outcome. Besides this, the group is also keen to address biomedical key scientific questions stemming from bedside with be the highest priority that can be translated and applied to medical care, which in turn will guarantee a return in product development and patenting. we also focused on different drug-based product development such as insect repellant and other cosmetic products. Several Group members have already established cross-link collaboration with other Research Groups in Iran, Brazil, and USA.